Category | GNRI high (> 104.25) | GNRI low (< 104.25) | P value |
---|---|---|---|
Age, years | |||
 ≤63 | 36 | 12 | 0.0013 |
 > 63 | 19 | 26 |  |
Sex | |||
 Male | 40 | 28 | 0.92 |
 Female | 15 | 10 |  |
Pathological T | |||
 pT0-2 | 28 | 11 | 0.035 |
 pT3-4 | 27 | 27 |  |
Pathological N | |||
 pN0 | 31 | 22 | 0.88 |
 pN1-2 | 24 | 16 |  |
Histology | |||
 Well/moderate | 49 | 32 | 0.49 |
 Poorly/signet/mucinous | 6 | 6 |  |
Lymphatic invasion | |||
 Absent | 31 | 22 | 0.88 |
 Present | 24 | 16 |  |
Venous invasion | |||
 Absent | 34 | 23 | 0.90 |
 Present | 21 | 15 |  |
Pathological response | |||
 Non-responder (grade0/1a/1b) | 32 | 27 | 0.21 |
 Responder (grade2/3) | 23 | 11 |  |
Radiation | |||
 Short course | 14 | 10 | 0.93 |
 Long course | 41 | 28 |  |
Adjuvant chemotherapy | |||
 Yes | 42 | 23 | 0.10 |
 No | 13 | 15 |  |
CA19-9 (ng/ml) | |||
 ≤ 37.0 | 47 | 28 | 0.16 |
 > 37.0 | 8 | 10 |  |
CEA (ng/ml) | |||
 ≤ 5 | 29 | 15 | 0.21 |
 > 5 | 26 | 23 |  |
Recurrence | |||
 Absent | 40 | 18 | 0.040 |
 Local | 4 | 7 |  |
 Distant | 11 | 13 |  |